Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gallinée is a microbiome-focused skincare and personal care company developing and marketing products designed to support the skin’s protective ecosystem. Founded by pharmacist Dr. Marie Drago, the brand formulates science-backed face, body, hair, oral care, and supplement products built around a patented complex of prebiotics, probiotics, and postbiotics. The company positions itself at the intersection of beauty, wellness, and skin microbiome science, with products intended to soothe, balance, and strengthen sensitive skin and scalp. Gallinée was acquired by Shiseido in September 2022 and continues to operate as an active brand within Shiseido’s portfolio. Its products are primarily marketed in Europe, especially the UK and France, and are manufactured in France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gallinée.